DE60136360D1 - Antigen aus streptococcus pyogenes - Google Patents

Antigen aus streptococcus pyogenes

Info

Publication number
DE60136360D1
DE60136360D1 DE60136360T DE60136360T DE60136360D1 DE 60136360 D1 DE60136360 D1 DE 60136360D1 DE 60136360 T DE60136360 T DE 60136360T DE 60136360 T DE60136360 T DE 60136360T DE 60136360 D1 DE60136360 D1 DE 60136360D1
Authority
DE
Germany
Prior art keywords
antigen
streptococcus pyogenes
streptococcus
prophylaxis
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136360T
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard Brodeur
Stephane Rioux
Martine Boyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Application granted granted Critical
Publication of DE60136360D1 publication Critical patent/DE60136360D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60136360T 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes Expired - Lifetime DE60136360D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06
PCT/CA2001/001001 WO2002004495A2 (en) 2000-07-06 2001-07-06 Streptococcus pyogenes antigen

Publications (1)

Publication Number Publication Date
DE60136360D1 true DE60136360D1 (de) 2008-12-11

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136360T Expired - Lifetime DE60136360D1 (de) 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (de)
EP (1) EP1297145B1 (de)
JP (1) JP4718099B2 (de)
AT (1) ATE412750T1 (de)
AU (1) AU7227001A (de)
BR (1) BR0112497A (de)
CA (1) CA2413576C (de)
DE (1) DE60136360D1 (de)
ES (1) ES2316458T3 (de)
WO (1) WO2002004495A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297145B1 (de) * 2000-07-06 2008-10-29 ID Biomedical Corporation Antigen aus streptococcus pyogenes
IL154853A0 (en) * 2000-10-27 2003-10-31 Chiron Spa Nucleic acids and proteins from streptococcus groups a & b
US7595057B2 (en) * 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
WO2005032582A2 (en) * 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP2612679A1 (de) * 2004-07-29 2013-07-10 Novartis Vaccines and Diagnostics, Inc. Immunogene Zusammensetzungen für grampositive Bakterien wie etwa Streptococcus agalactiae
WO2006042027A2 (en) * 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
DK2054431T3 (da) * 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
JP2010508276A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 化膿連鎖球菌のための免疫原性組成物および治療組成物
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
DK2235046T3 (da) 2007-12-21 2012-10-29 Novartis Ag Mutante former af streptolysin-O
CA2838981C (en) 2011-06-17 2020-09-08 University Of Tennessee Research Foundation Group a streptococcus multivalent vaccine
EP2953641A4 (de) 2013-02-11 2016-11-16 Univ Tennessee Res Foundation Gruppe-a-streptokokken-m-verwandte proteine und verfahren zur verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (de) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
EP1297145B1 (de) 2000-07-06 2008-10-29 ID Biomedical Corporation Antigen aus streptococcus pyogenes

Also Published As

Publication number Publication date
JP2004502446A (ja) 2004-01-29
US20030165528A1 (en) 2003-09-04
ES2316458T3 (es) 2009-04-16
US7811585B2 (en) 2010-10-12
JP4718099B2 (ja) 2011-07-06
EP1297145A2 (de) 2003-04-02
WO2002004495A3 (en) 2002-06-13
US20080038268A1 (en) 2008-02-14
CA2413576C (en) 2012-11-13
CA2413576A1 (en) 2002-01-17
AU7227001A (en) 2002-01-21
WO2002004495A2 (en) 2002-01-17
BR0112497A (pt) 2003-11-25
EP1297145B1 (de) 2008-10-29
US7247308B2 (en) 2007-07-24
ATE412750T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
BE2021C506I2 (de)
ATE412750T1 (de) Antigen aus streptococcus pyogenes
ATE542829T1 (de) Impfstoff
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2004030608A3 (en) Nanoemulsion vaccines
NO20024246L (no) Endret stamme av det modifiserte vacciniaviruset (Ankara MVA)
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MY125202A (en) Vaccine
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
ATE426026T1 (de) Chimare arterivirus-ahnliche partikel
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
AP2002002685A0 (en) Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
AP2003002734A0 (en) Purification of HBV antigens for use in vaccines.
DE60226175D1 (de) Mycobakterieller impfstoff
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
ATE456659T1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
EP1543838A4 (de) Vakzine gegen infektiöse katzen-peritonitis
SG147465A1 (en) Vaccine
DK0792347T3 (da) Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme
ATE452191T1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition